WASHINGTON (Reuters) – German drug and crop chemical maker Bayer AG’s bid to buy seed and chemical company Monsanto Co is on track to win U.S. antitrust approval by the end of May, unless there is a last-minute complication, a source familiar with the matter said on Thursday.
Source:: Reuters – Business News
